Search Results 1031-1040 of 33277 for Injection

  1. Zanidatamab-hrii (intravenous route) - Side effects & uses - Mayo Clinic

    Zanidatamab-hrii injection is used to treat HER2-positive (IHC 3+) biliary tract cancer (BTC) that has spread (metastatic) or cannot be removed by surgery ( ...

  2. Brian E. Grogg, M.D. - Doctors and Medical Staff - Mayo Clinic

    Injection; Intramuscular injection; Joint examination; Joint injection; Musculoskeletal exam; Platelet rich plasma injection; Regenerative medicine therapy ...

  3. Japanese encephalitis virus vaccine (intramuscular route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  4. Hormone therapy for prostate cancer - Mayo Clinic

    These medicines stop the testicles from making testosterone. Most of these medicines are given as a shot, also called an injection. The shots go under the skin ...

  5. Botox injections - Doctors & Departments - Mayo Clinic

    Learn about the uses, risks and results of this treatment for facial wrinkles and medical conditions, such as migraine and heavy sweating.

  6. Retifanlimab-dlwr (intravenous route) - Side effects & uses - Mayo Clinic

    Retifanlimab-dlwr injection is used in combination with other cancer medicines (eg, carboplatin, paclitaxel) as first-line treatment for a type of anal cancer ...

  7. Plasminogen, human-tvmh (intravenous route) - Side effects & uses - Mayo Clinic

    Plasminogen, human-tvmh injection is used to treat plasminogen deficiency type 1 (hypoplasminogenemia). It works by increasing the plasminogen levels in the ...

  8. Eravacycline (intravenous route) - Side effects & uses - Mayo Clinic

    Eravacycline injection is used to treat complicated intra-abdominal (within the stomach area) infections (cIAI) caused by bacteria. This medicine is to be ...

  9. Knee Arthritis Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine the safety and feasibility of autologous, adipose derived stromal vascular fraction injections in the treatment of ...

  10. Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

    Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple ...